Literature DB >> 19836159

Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.

Susan L Tucker1, Hekun Jin, Xiong Wei, Shulian Wang, Mary K Martel, Ritsuko Komaki, H Helen Liu, Radhe Mohan, Yuhchyau Chen, James D Cox, Zhongxing Liao.   

Abstract

PURPOSE: To compute the risk of radiation pneumonitis (RP) as a function of mean lung dose (MLD), with RP scored using three grading systems and analyzed at four threshold levels of toxicity in a large cohort of patients with non-small cell lung cancer (NSCLC) treated with definitive radiotherapy (RT). METHODS AND MATERIALS: On the basis of medical records and radiographic images, RP was scored retrospectively in 442 patients with NSCLC who had >or=6 months of follow-up after the end of RT. The severity of RP was scored for each patient using the National Cancer Institute (NCI) Common Toxicity Criteria, version 2.0 (CTC2.0); the NCI Common Terminology Criteria for Adverse Events, version 3.0 (CTCAE3.0); and the grading system of the Radiation Therapy Oncology Group (RTOG). For each grading system and for each of four levels of toxicity (Grade >or=1, >or=2, >or=3, >or=4), the Lyman, logistic, and log-logistic normal tissue complication probability (NTCP) models were fitted to the data as functions of MLD. The parameter estimates from the model fits are listed in table form, and the RP risk estimates are presented graphically for the Lyman and log-logistic NTCP models.
RESULTS: The results presented here illustrate the impact of scoring system and level of toxicity on the relationship between MLD and RP risk.
CONCLUSIONS: These results facilitate quantitative comparisons between our data and studies of RP risk reported by others, and several examples of such comparisons are provided. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19836159     DOI: 10.1016/j.ijrobp.2009.05.055

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

Review 1.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

2.  Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance.

Authors:  J J Gordon; K Snyder; H Zhong; K Barton; Z Sun; I J Chetty; M Matuszak; R K Ten Haken
Journal:  Phys Med Biol       Date:  2015-08-21       Impact factor: 3.609

3.  Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.

Authors:  Richard Thomas; Yu-Hui Chen; Hiroto Hatabu; Raymond H Mak; Mizuki Nishino
Journal:  Lung Cancer       Date:  2020-04-30       Impact factor: 5.705

4.  The mean lung dose (MLD) : predictive criterion for lung damage?

Authors:  Thomas Herrmann; Peter Geyer; Steffen Appold
Journal:  Strahlenther Onkol       Date:  2015-04-13       Impact factor: 3.621

5.  Quantitative Analysis of Radiation-Associated Parenchymal Lung Change.

Authors:  Edward Chandy; Adam Szmul; Alkisti Stavropoulou; Joseph Jacob; Catarina Veiga; David Landau; James Wilson; Sarah Gulliford; John D Fenwick; Maria A Hawkins; Crispin Hiley; Jamie R McClelland
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

6.  Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Richard Castillo; Edward Castillo; Leah Schubert; Bernard L Jones; Austin Faught; Laurie E Gaspar; Jennifer Kwak; Daniel W Bowles; Timothy Waxweiler; Jingjing M Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Inga Grills; Chad G Rusthoven; Thomas Guerrero
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-09       Impact factor: 7.038

7.  Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy.

Authors:  Sibo Tian; Jeffrey M Switchenko; Richard J Cassidy; Chase E Escott; Richard Castillo; Pretesh R Patel; Walter J Curran; Kristin A Higgins
Journal:  Transl Lung Cancer Res       Date:  2019-02

Review 8.  Complications from Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Kylie H Kang; Christian C Okoye; Ravi B Patel; Shankar Siva; Tithi Biswas; Rodney J Ellis; Min Yao; Mitchell Machtay; Simon S Lo
Journal:  Cancers (Basel)       Date:  2015-06-15       Impact factor: 6.639

9.  Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats.

Authors:  Xianglan Zhang; You Keun Shin; Zhenlong Zheng; Lianhua Zhu; Ik Jae Lee
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

10.  Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer.

Authors:  Yoshihiko Manabe; Yuta Shibamoto; Chikao Sugie; Akihiro Hayashi; Taro Murai; Takeshi Yanagi
Journal:  Technol Cancer Res Treat       Date:  2014-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.